Jarrod Longcor
2023
In 2023, Jarrod Longcor earned a total compensation of $1.4M as Chief Operating Officer at Cellectar Biosciences, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $288,000 |
|---|---|
| Option Awards | $394,560 |
| Salary | $480,000 |
| Stock Awards | $113,758 |
| Other | $86,242 |
| Total | $1,362,560 |
Longcor received $480K in salary, accounting for 35% of the total pay in 2023.
Longcor also received $288K in non-equity incentive plan, $394.6K in option awards, $113.8K in stock awards and $86.2K in other compensation.
Rankings
In 2023, Jarrod Longcor's compensation ranked 880th out of 2,978 executives tracked by ExecPay. In other words, Longcor earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 880 out of 2,978 | 70th |
Division Manufacturing | 514 out of 1,637 | 69th |
Major group Chemicals And Allied Products | 350 out of 906 | 61st |
Industry group Drugs | 340 out of 869 | 61st |
Industry Pharmaceutical Preparations | 231 out of 627 | 63rd |
Source: SEC filing on April 26, 2024.
Longcor's colleagues
We found two more compensation records of executives who worked with Jarrod Longcor at Cellectar Biosciences in 2023.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019